The hormone adrenomedullin disrupts insulin signaling in blood vessel cells, contributing to systemic insulin resistance in obesity-associated type 2 diabetes, according to a new study.

These days, many devices are programmed through apps on patients’ phones. But the FDA warns that certain phone settings, such ...

Medtronic's stock lags peers due to growth challenges in the diabetes and hypertension markets. See why we recommend a sell ...

There’s an ongoing push to improve health care affordability and reduce out-of-pocket costs, especially for prescription ...

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

Low-fat diets are problematic, says world-renowned internist and regenerative physician Michael Aziz, MD, author of the ...

The vegan diet has many health and environmental benefits. Find the benefits of the vegan diet here. The post These are 10 ...

The hormone adrenomedullin disrupts insulin signaling in blood vessel cells, contributing to systemic insulin resistance in obesity-associated type 2 ...

Adjusted EBITDA margin increased to 37.2% from 25.2% in Q4 2024, driven by cost reductions and operational improvements. Management's tone shifted positively, highlighting stronger-than-expected ...

Lance Bass gave a health update to PEOPLE, sharing that his diabetes is “finally under control” and he’s been "experimenting" ...

Managing diabetes is even harder when temperatures and humidity are rising. Find out how extreme heat can negatively affect ...